Related Experiment Videos
Longitudinal evaluation of glomerular filtration rate during long-term lithium therapy
Insights
Long-term lithium therapy did not significantly alter kidney function in seven patients over 7.5 years. This study supports the preservation of glomerular filtration rate (GFR) during continuous lithium treatment.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Lithium is widely used for bipolar disorder and has known renal effects.
- The potential for lithium to cause chronic interstitial nephritis and reduced glomerular filtration rate (GFR) remains a critical, unanswered question.
- Previous cross-sectional studies lack prospective data on creatinine clearance during lithium therapy.
Purpose of the Study:
- To prospectively evaluate the long-term effects of lithium therapy on GFR.
- To determine if continuous lithium treatment leads to a decline in renal function.
Main Methods:
- A longitudinal study involving seven patients undergoing continuous lithium therapy.
- Creatinine clearance measurements were obtained at the beginning and after an average of 7.5 years of lithium treatment.
Main Results:
- No significant changes were observed in mean serum creatinine concentration over the study period.
- Average creatinine clearance remained stable, with initial values of 99 +/- 8 mL/min/1.73 m2 and follow-up values of 105 +/- 4 mL/min/1.73 m2.
- These findings indicate preservation of GFR during extended lithium administration.
Conclusions:
- Long-term lithium therapy appears to preserve glomerular filtration rate.
- The study provides prospective evidence against lithium-induced chronic interstitial nephritis causing significant GFR reduction.
Abstract:
Lithium produces many renal effects, but the important question of whether or not it causes chronic interstitial nephritis with consequent reduced glomerular filtration rate (GFR) remains unanswered. The several studies carried out in this area have been cross-sectional and, therefore, have not contained prospective information regarding creatinine clearance. The present study provides data from seven patients in whom creatinine clearances were obtained bracketing an average span of 7.5 years of continuous lithium therapy. Over this time, there was no significant change either in mean serum creatinine concentration or in average creatinine clearance (first determination: 1.1 +/- 0.1 [SE] mg/dL, 99 +/- 8 mL/min/1.73 m2; second determination 1.0 +/- 0.1, 105 +/- 4, respectively). The data, thus, support preservation of GFR during long-term lithium therapy.